These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23415595)

  • 1. Brachytherapy and MRI: seeing what we are missing.
    Riaz N; Zelefsky MJ
    Brachytherapy; 2013; 12(3):203. PubMed ID: 23415595
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on "Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy".
    Wallner KE
    Brachytherapy; 2013; 12(3):202. PubMed ID: 23415049
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment.
    Labanaris AP
    J Urol; 2013 Mar; 189(3):866. PubMed ID: 23261235
    [No Abstract]   [Full Text] [Related]  

  • 4. Words of wisdom: re: transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer.
    Ravery V
    Eur Urol; 2013 Aug; 64(2):337. PubMed ID: 23830225
    [No Abstract]   [Full Text] [Related]  

  • 5. MRI-guided diagnosis and treatment of prostate cancer.
    D'Amico AV; Cormack RA; Tempany CM
    N Engl J Med; 2001 Mar; 344(10):776-7. PubMed ID: 11236795
    [No Abstract]   [Full Text] [Related]  

  • 6. Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.
    Hegde JV; Demanes DJ; Veruttipong D; Raince J; Park SJ; Raman SS; Nickols NG; King CR; Kishan AU; Steinberg ML; Kamrava M
    Brachytherapy; 2017; 16(6):1106-1112. PubMed ID: 28807747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Small Acinar Proliferation and High-grade Prostatic Intraepithelial Neoplasia in the Era of Multiparametric Magnetic Resonance Imaging: A Contemporary Review.
    Manning TG; Cheung E; Perera M; Christidis D; O'Brien JS; Mitchell C; Bolton DM; Lawrentschuk N
    Urology; 2017 Sep; 107():5-10. PubMed ID: 28438627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
    De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
    Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deformable registration of trans-rectal ultrasound (TRUS) and magnetic resonance imaging (MRI) for focal prostate brachytherapy.
    Mayer A; Zholkover A; Portnoy O; Raviv G; Konen E; Symon Z
    Int J Comput Assist Radiol Surg; 2016 Jun; 11(6):1015-23. PubMed ID: 27017500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy.
    Taneja SS
    J Urol; 2013 Oct; 190(4):1245-6. PubMed ID: 24029308
    [No Abstract]   [Full Text] [Related]  

  • 11. 3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.
    Kirilova A; Damyanovich A; Crook J; Jezioranski J; Wallace K; Pintilie M
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):371-8. PubMed ID: 20421147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
    Naiki T; Okamura T; Nagata D; Mori Y; Kawai N; Ogawa K; Akita H; Hashimoto Y; Tozawa K; Kohri K
    Asian Pac J Cancer Prev; 2011; 12(4):909-13. PubMed ID: 21790224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy.
    Crook J; Patil N; Ma C; McLean M; Borg J
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1079-84. PubMed ID: 19879700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy.
    Dubois DF; Prestidge BR; Hotchkiss LA; Prete JJ; Bice WS
    Radiology; 1998 Jun; 207(3):785-9. PubMed ID: 9609905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
    Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
    AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply by author.
    J Urol; 2013 Sep; 190(3):1140. PubMed ID: 23770372
    [No Abstract]   [Full Text] [Related]  

  • 17. To biopsy or not to biopsy: minimizing the risk of prostate needle biopsy.
    Kibel AS
    J Urol; 2013 Mar; 189(3):796-7. PubMed ID: 23246850
    [No Abstract]   [Full Text] [Related]  

  • 18. Words of wisdom. Re: Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy.
    Villers A
    Eur Urol; 2014 Jun; 65(6):1218-9. PubMed ID: 24774825
    [No Abstract]   [Full Text] [Related]  

  • 19. MRI/TRUS data fusion for brachytherapy.
    Daanen V; Gastaldo J; Giraud JY; Fourneret P; Descotes JL; Bolla M; Collomb D; Troccaz J
    Int J Med Robot; 2006 Sep; 2(3):256-61. PubMed ID: 17520640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of artificial intelligence in the assessment of prostate pathology.
    Egevad L; Ström P; Kartasalo K; Olsson H; Samaratunga H; Delahunt B; Eklund M
    Histopathology; 2020 May; 76(6):790-792. PubMed ID: 32402150
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.